The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin: Systematic Review and Meta-analysis of Randomized Controlled Trials
Abstract
CONTEXT: In the United States, an estimated 2 million persons have neuropathic pain that is often resistant to therapy. The use of opioids for neuropathic pain remains controversial, in part because studies have been small, have yielded equivocal results, and have not established the long-term risk-benefit ratio of this treatment. OBJECTIVE: To assess the efficacy and safety of opioid agonists for the treatment of neuropathic pain based on published randomized controlled trials (RCTs). DATA SOURCES: We searched MEDLINE (1966 to December 2004) and the Cochrane Central Register of Controlled Trials (fourth quarter, 2004) for articles in any language, along with reference lists of reviews and retrieved articles, using a combination of 9 search terms for RCTs with 32 terms for opioids and 15 terms for neuropathic pain. STUDY SELECTION: Trials were included in which opioid agonists were given to treat central or peripheral neuropathic pain of any etiology, pain was assessed using validated instruments, and adverse events were reported. Studies in which drugs other than opioid agonists were combined with opioids or opioids were administered epidurally or intrathecally were excluded. DATA EXTRACTION: Data were extracted by 2 independent investigators and included demographic variables, diagnoses, interventions, efficacy, and adverse effects. DATA SYNTHESIS: Twenty-two articles met inclusion criteria and were classified as short-term (less than 24 hours; n = 14) or intermediate-term (median = 28 days; range = 8-56 days; n = 8) trials. The short-term trials had contradictory results. In contrast, all 8 intermediate-term trials demonstrated opioid efficacy for spontaneous neuropathic pain. A fixed-effects model meta-analysis of 6 intermediate-term studies showed mean posttreatment visual analog scale scores of pain intensity after opioids to be 14 units lower on a scale from 0 to 100 than after placebo (95% confidence interval [CI], -18 to -10; P<.001). According to number needed to harm (NNH), the most common adverse event was nausea (NNH, 3.6; 95% CI, 2.9-4.8), followed by constipation (NNH, 4.6; 95% CI, 3.4-7.1), drowsiness (NNH, 5.3; 95% CI, 3.7-8.3), vomiting (NNH, 6.2; 95% CI, 4.6-11.1), and dizziness (NNH, 6.7; 95% CI, 4.8-10.0). CONCLUSIONS: Short-term studies provide only equivocal evidence regarding the efficacy of opioids in reducing the intensity of neuropathic pain. Intermediate-term studies demonstrate significant efficacy of opioids over placebo for neuropathic pain, which is likely to be clinically important. Reported adverse events of opioids are common but not life-threatening. Further RCTs are needed to establish their long-term efficacy, safety (including addiction potential), and effects on quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885 · cited 2×
“6 μg/kg per min for 17-21 min Ketamine: 60 μg/kg over 5 min 6 μg/kg per min for 17-21 min Placebo 4 Median (IQR): 20 (4-50) vs 0 (0-8)”
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Defining the clinically important difference in pain outcome measures
Farrar, J. T., Portenoy, R. K., Berlin, J. A., Kinman, J. L., & Strom, B. L. (2000) · Pain · doi:10.1016/s0304-3959(00)00339-0 · Cited by 1,071
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Arnér, S., & Meyerson, B. A. (1988) · Pain · doi:10.1016/0304-3959(88)90198-4 · Cited by 991
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Raja, S. N., Haythornthwaite, J. A., Pappagallo, M., Clark, M. R., Travison, T. G., Sabeen, S., Royall, R. M., & Max, M. B. (2002) · Neurology · doi:10.1212/wnl.59.7.1015 · Cited by 593
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
Rowbotham, M. C., Twilling, L., Davies, P. S., Reisner, L., Taylor, K., & Mohr, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021420 · Cited by 529
What decline in pain intensity is meaningful to patients with acute pain?
Cepeda, S. M., Africano, J. M., Polo, R., Alcala, R., & Carr, D. B. (2003) · Pain · doi:10.1016/s0304-3959(03)00176-3 · Cited by 519
Self-citationWatson, P. C. N., Moulin, D., Watt-Watson, J., Gordon, A., & Eisenhoffer, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00160-x · Cited by 510
Eide, P. K., Jørum, E., Stubhaug, A., Bremnes, J., & Breivik, H. (1994) · Pain · doi:10.1016/0304-3959(94)90129-5 · Cited by 490
Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
Rowbotham, M. C., Reisner-Keller, L. A., & Fields, H. L. (1991) · Neurology · doi:10.1212/wnl.41.7.1024 · Cited by 477
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review
McNicol, E., Horowicz-Mehler, N., Fisk, R. A., Bennett, K., Gialeli-Goudas, M., Chew, P. W., Lau, J., & Carr, D. (2003) · The Journal of Pain · doi:10.1016/s1526-5900(03)00556-x · Cited by 466
Self-citationThe effect of opioids on phantom limb pain and cortical reorganization
Huse, E., Larbig, W., Flor, H., & Birbaumer, N. (2001) · Pain · doi:10.1016/s0304-3959(00)00385-7 · Cited by 309
An Updated Interdisciplinary Clinical Pathway for CRPS: Report of an Expert Panel
Stanton‐Hicks, M. D., Burton, A. W., Bruehl, S. P., Carr, D. B., Harden, R. N., Hassenbusch, S. J., Lubenow, T. R., Oakley, J. C., Racz, G. B., Raj, P. P., et al. (2002) · Pain Practice · doi:10.1046/j.1533-2500.2002.02009.x · Cited by 294
Self-citationDuehmke, R. M., Hollingshead, J., & Cornblath, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub3 · Cited by 267
Max, M. B., Schafer, S. C., Culnane, M., Dubner, R., & Gracely, R. H. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.44 · Cited by 247
Eide, P. K., Stubhaug, A., & Stenehjem, A. E. (1995) · Neurosurgery · doi:10.1227/00006123-199512000-00007 · Cited by 235
Are opioids effective in relieving neuropathic pain?
Dellemijn, P. (1999) · Pain · doi:10.1016/s0304-3959(98)00256-5 · Cited by 225
Effects of IV morphine in central pain: A randomized placebo-controlled study
Attal, N., Guirimand, F., Brasseur, L., Gaude, V., Chauvin, M., & Bouhassira, D. (2002) · Neurology · doi:10.1212/wnl.58.4.554 · Cited by 224
Kupers, R. C., Konings, H., Adriaensen, H., & Gybels, J. M. (1991) · Pain · doi:10.1016/0304-3959(91)90004-h · Cited by 206
Dellemijn, P. L., & Vanneste, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09024-1 · Cited by 204
Jadad, A. R., Carroll, D., Glynn, C. J., McQuay, H. J., & Moore, R. A. (1992) · The Lancet · doi:10.1016/0140-6736(92)91194-d · Cited by 200
Wu, C. L., Tella, P., Staats, P. S., Vaslav, R., Kazim, D. A., Wesselmann, U., & Raja, S. N. (2002) · Anesthesiology · doi:10.1097/00000542-200204000-00010 · Cited by 197
Jørum, E., Warncke, T., & Stubhaug, A. (2003) · Pain · doi:10.1016/s0304-3959(02)00122-7 · Cited by 196
Systemic lidocaine in pain due to peripheral nerve injury and predictors of response
Attal, N., Rouaud, J., Brasseur, L., Chauvin, M., & Bouhassira, D. (2004) · Neurology · doi:10.1212/01.wnl.0000103237.62009.77 · Cited by 194
Harke, H., Gretenkort, P., Ladleif, H. U., Rahman, S., & Harke, O. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00039 · Cited by 189
Max, M. B., Byas-Smith, M. G., Gracely, R. H., & Bennett, G. J. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199508000-00008 · Cited by 170
Dunbar, S. A., & Katz, N. P. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00165-4 · Cited by 163
Leung, A., Wallace, M. S., Ridgeway, B., & Yaksh, T. (2001) · Pain · doi:10.1016/s0304-3959(00)00433-4 · Cited by 159
Opioids and Chronic Neuropathic Pain
Foley, K. M. (2003) · New England Journal of Medicine · doi:10.1056/nejme030014 · Cited by 158
Morley, J. S., Bridson, J. D., Nash, T. P., Miles, J. B., White, S. J., & Makin, M. K. (2003) · Palliative Medicine · doi:10.1191/0269216303pm815oa · Cited by 157
Maier, C., Hildebrandt, J., Klinger, R., Henrich-Eberl, C., & Lindena, G. (2002) · Pain · doi:10.1016/s0304-3959(02)00020-9 · Cited by 156
Rabben, T., Skjelbred, P., & Øye, I. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38236-9 · Cited by 149
Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
Benedetti, F., Vighetti, S., Amanzio, M., Casadio, C., OLIARO, A., Bergamasco, B., & Maggi, G. (1998) · Pain · doi:10.1016/s0304-3959(97)00172-3 · Cited by 133
Nonsteroidal Anti-Inflammatory Drugs, Alone or Combined With Opioids, for Cancer Pain
McNicol, E. D., Strassels, S. A., Goudas, L. C., Lau, J., & Carr, D. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.524 · Cited by 116
Self-citationEvidence Report on the Treatment of Pain in Cancer Patients
Carr, D. B., Goudas, L. C., Balk, E. M., Bloch, R., Ioannidis, J., & Lau, J. (2004) · JNCI Monographs · doi:10.1093/jncimonographs/lgh012 · Cited by 108
Self-citationSympathectomy for neuropathic pain
Mailis, A., & Furlan, A. D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002918 · Cited by 90
Kaiman, S., Österberg, A., Sörensen, J., et al. (2002) · European Journal of Pain · doi:10.1053/eujp.2001.0307 · Cited by 70
Sullivan, M. D., & FERRELL, B. R. (2004) · Journal of Pain · doi:10.1016/j.jpain.2004.10.006 · Cited by 64
McQuay, H. J. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04634.x · Cited by 53
Cohen, S. P., Chang, A. S., Larkin, T. M., & Mao, J. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000136953.11583.7b · Cited by 39
Cited by
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Pharmacological Management of Persistent Pain in Older Persons
American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02376.x · Cited by 1,008
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Metadata
- Authors
- Eisenberg, E., McNicol, E. D., & Carr, D. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-22
- Volume
- 293
- Issue
- 24
- Pages
- 3043
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2143538143
- Cited by
- 407
- References
- 46
- FWCI
- 44.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.